# Study of APD421 With and Without Ondansetron

> **NCT03583489** · PHASE1 · COMPLETED · sponsor: **Acacia Pharma Ltd** · enrollment: 30 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** APD421
- **DRUG:** Placebo
- **DRUG:** Ondansetron

## Key facts

- **NCT ID:** NCT03583489
- **Lead sponsor:** Acacia Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-17
- **Primary completion:** 2018-08-13
- **Final completion:** 2018-08-13
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03583489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03583489, "Study of APD421 With and Without Ondansetron". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03583489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*